Publication at Faculty of Medicine in Pilsen |
2021
Abstract
Hypomagnesaemia is a complication mainly associated with treatment with cisplatin and anti-EGFR antibodies. Early magnesium substitution is important to prevent increased neuromuscular irritability when magnesium decreases to 0.5 mmol / l.
In case of severe symptoms, intravenous magnesium substitution is necessary, usually repeatedly, and discontinuation of cancer treatment should be considered.